dipyridamole has been researched along with 1,1-diphenyl-2-picrylhydrazyl in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blair, P; Chakrabarti, S; Freedman, JE; Wu, C | 1 |
1 other study(ies) available for dipyridamole and 1,1-diphenyl-2-picrylhydrazyl
| Article | Year |
|---|---|
Redox state of dipyridamole is a critical determinant for its beneficial antioxidant and antiinflammatory effects.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biphenyl Compounds; Blood Platelets; CD40 Ligand; Cell Adhesion Molecules; Dipyridamole; Endothelial Cells; Ferric Compounds; HL-60 Cells; Humans; Hydrazines; Hydrogen Peroxide; I-kappa B Proteins; Lipoproteins, LDL; Mice; Mice, Inbred C57BL; Microfilament Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidation-Reduction; Phosphoproteins; Phosphorylation; Picrates; Platelet Adhesiveness; Reactive Oxygen Species; Spectrometry, Fluorescence; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2007 |